O. Piot

1.1k total citations
24 papers, 754 citations indexed

About

O. Piot is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, O. Piot has authored 24 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in O. Piot's work include Neuroscience and Neuropharmacology Research (12 papers), Receptor Mechanisms and Signaling (9 papers) and Neuropeptides and Animal Physiology (5 papers). O. Piot is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Receptor Mechanisms and Signaling (9 papers) and Neuropeptides and Animal Physiology (5 papers). O. Piot collaborates with scholars based in France and Italy. O. Piot's co-authors include J.C. Blanchard, Georg Andrees Böhme, Adam Doble, J.M. Stutzmann, M. Reibaud, Corentin Bon, Jean‐Charles Blanchard, Jean Rataud, B.P. Roques and Martine Lemaire‐Chamley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

O. Piot

23 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Piot France 14 469 287 187 113 112 24 754
Carol J. Grossman United Kingdom 7 585 1.2× 475 1.7× 123 0.7× 92 0.8× 71 0.6× 8 1.0k
J.M. Stutzmann France 18 708 1.5× 377 1.3× 214 1.1× 79 0.7× 195 1.7× 39 1.1k
Felix Brugger Switzerland 17 794 1.7× 544 1.9× 208 1.1× 71 0.6× 146 1.3× 23 1.1k
Dinah Weissmann France 21 640 1.4× 474 1.7× 139 0.7× 84 0.7× 86 0.8× 53 1.1k
C M Fattaccini France 14 866 1.8× 527 1.8× 198 1.1× 127 1.1× 118 1.1× 15 1.1k
Marco Orsetti Italy 15 308 0.7× 290 1.0× 79 0.4× 85 0.8× 166 1.5× 49 833
Robert A. McArthur Italy 20 538 1.1× 344 1.2× 201 1.1× 89 0.8× 94 0.8× 43 1.2k
Mark D. Black United States 17 595 1.3× 437 1.5× 159 0.9× 117 1.0× 110 1.0× 28 958
Akira Horita United States 17 467 1.0× 309 1.1× 141 0.8× 92 0.8× 93 0.8× 30 883
J�rgen Engel Sweden 17 636 1.4× 344 1.2× 103 0.6× 75 0.7× 122 1.1× 25 892

Countries citing papers authored by O. Piot

Since Specialization
Citations

This map shows the geographic impact of O. Piot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Piot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Piot more than expected).

Fields of papers citing papers by O. Piot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Piot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Piot. The network helps show where O. Piot may publish in the future.

Co-authorship network of co-authors of O. Piot

This figure shows the co-authorship network connecting the top 25 collaborators of O. Piot. A scholar is included among the top collaborators of O. Piot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Piot. O. Piot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piot, O., et al.. (1995). Comparative behavioural profile of centrally administered tachykinin NK1, NK2and NK3receptor agonists in the guinea‐pig. British Journal of Pharmacology. 116(5). 2496–2502. 13 indexed citations
2.
Doble, Adam, et al.. (1995). The mechanism of action of zopiclone. European Psychiatry. 10(S3). 117s–128s. 28 indexed citations
3.
Jimonet, Patrick, Magalie Barreau, J.C. Blanchard, et al.. (1994). Synthesis, anticonvulsant and neuroprotective activities of RP 66055, a riluzole derivative. Bioorganic & Medicinal Chemistry. 2(8). 793–798. 15 indexed citations
4.
Böhme, Georg Andrees, et al.. (1994). CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats. Psychopharmacology. 115(4). 435–440. 49 indexed citations
5.
Damour, Dominique, et al.. (1994). 1,1-diphenyl-3-dialkylamino-1-silacyclopentane derivatives: A new class of potent and selective 5-HT2A antagonists. Bioorganic & Medicinal Chemistry Letters. 4(3). 415–420. 7 indexed citations
6.
Piot, O., et al.. (1994). Different behavioral profiles of specific tachykinin receptor agonists in guinea-pigs. Neuropeptides. 26. 37–37. 1 indexed citations
7.
Barnéoud, Pascal, Georg Andrees Böhme, O. Piot, et al.. (1994). CCK-A and CCK-B receptors enhance olfactory recognition via distinct neuronal pathways.. Learning & Memory. 1(3). 153–164. 25 indexed citations
8.
Guérémy, C., et al.. (1993). New indole derivatives as potent and selective serotonin uptake inhibitors. Journal of Medicinal Chemistry. 36(9). 1194–1202. 22 indexed citations
9.
Stutzmann, J.M., O. Piot, M. Reibaud, Adam Doble, & J.C. Blanchard. (1993). Pharmacological properties and mechanism of action of the cyclopyrrolones.. PubMed. 18(4). 393–400. 11 indexed citations
10.
Doble, Adam, Thierry Canton, O. Piot, et al.. (1993). RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.. Journal of Pharmacology and Experimental Therapeutics. 266(3). 1213–1226. 7 indexed citations
11.
Böhme, Georg Andrees, Corentin Bon, M. Reibaud, et al.. (1993). Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats.. Proceedings of the National Academy of Sciences. 90(19). 9191–9194. 294 indexed citations
12.
Lemaire‐Chamley, Martine, O. Piot, Bernárd P. Roques, Georg Andrees Böhme, & Jean‐Charles Blanchard. (1992). Evidence for an endogenous cholecystokininergic balance in social memory. Neuroreport. 3(10). 929–932. 57 indexed citations
13.
Doble, Adam, D. Girdlestone, O. Piot, et al.. (1992). Pharmacological characterization of RP 62203, a novel 5‐hydroxytryptamine 5‐HT2 receptor antagonist. British Journal of Pharmacology. 105(1). 27–36. 38 indexed citations
14.
Reibaud, M., O. Piot, Jean Rataud, J.M. Stutzmann, & J.C. Blanchard. (1992). ANXIOLYTIC PROPERTIES OF SURICLONE, A CYCLOPYRROLONE DERIVATIVE ACTING AT THE GABA RECEPTOR-COMPLEX.. Clinical Neuropharmacology. 15. 545B–545B. 1 indexed citations
15.
Stutzmann, J.M., et al.. (1991). Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?. Neuroscience Letters. 128(1). 4–8. 39 indexed citations
16.
Guérémy, C., et al.. (1991). Naphthosultam derivatives: a new class of potent and selective 5-HT2 antagonists. Journal of Medicinal Chemistry. 34(8). 2477–2483. 31 indexed citations
17.
Rataud, Jean, et al.. (1991). ‘Anxiolytic’ effect of CCK-antagonists on plus-maze behavior in mice. Brain Research. 548(1-2). 315–317. 65 indexed citations
18.
Stutzmann, J.M., O. Piot, Jean Rataud, M. Bardone, & J.C. Blanchard. (1991). Behavioural and electrocorticographic studies in rodents with RP 59037, a cyclopyrrolone derivative partial agonist at the GABA receptor-complex. European Neuropsychopharmacology. 1(3). 397–397. 1 indexed citations
19.
Piot, O., et al.. (1990). Cyclopyrrolones, unlike some benzodiazepines, do not induce physical dependence in mice. Neuroscience Letters. 117(1-2). 140–143. 17 indexed citations
20.
Piot, O., J.M. Stutzmann, J.C. Blanchard, & Pierre M. Laduron. (1990). RP 62203, a naphtosultam derivative with potent and selective 5-HT2 antagonist properties: II behavioral profile. European Journal of Pharmacology. 183(5). 1959–1960. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026